Myelodysplastic Syndrome (MDS)-Determining Clonal Events at Presentation of Aplastic Anemia (AA)

被引：0
|
作者：
Negoro, Eiju [1 ]
Hosono, Naoko [2 ]
Shen, Wenyi [3 ]
Yoshizato, Tetsuichi [4 ]
Patel, Bhumika J. [1 ]
Hirsh, Cassandra [1 ]
Przychodzen, Bartlomiej [1 ]
Clemente, Michael J. [1 ]
Mahfouz, Reda Z. [1 ]
Wodnar-Filipowicz, Aleksandra [5 ]
Makishima, Hideki [4 ]
Ogawa, Seishi [4 ]
Sekeres, Mikkael A. [6 ]
Maciejewski, Jaroslaw P. [1 ]
机构：
[1] Cleveland Clin, Taussing Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
[2] Univ Fukui, Dept Hematol & Oncol, Fukui 910, Japan
[3] Nanjing Med Univ, Affilliated Hospitla 1, Nanjing, Jiangsu, Peoples R China
[4] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan
[5] Univ Basel Hosp, CH-4031 Basel, Switzerland
[6] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Risk factors for evolution of myelodysplastic syndrome (MDS) after immunosuppressive therapy in children with aplastic anemia.
    Ohara, A
    Kojima, S
    Tsuchida, M
    Kudo, T
    Hanada, R
    Okimoto, Y
    Kaneko, T
    Takano, T
    Tsukimoto, I
    BLOOD, 2000, 96 (11) : 147A - 147A
  • [22] Hypoplastic Myelodysplastic Syndrome (h-MDS) Is a Distinctive Clinical Entity with Poorer Prognosis and Frequent Karyotypic and FISH Abnormalities Compared to Aplastic Anemia (AA)
    Koh, Youngil
    Lee, Hye Ryun
    Song, Eun Young
    Kim, Hyun Kyoung
    Kim, Inho
    Yoon, Sung-Soo
    Lee, Dong Soon
    Park, Seonyang
    Park, Myoung Hee
    Kim, Byoung Kook
    BLOOD, 2009, 114 (22) : 1239 - 1240
  • [23] Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA)
    Koh, Youngil
    Lee, Hye Ryun
    Song, Eun Young
    Kim, Hyun Kyoung
    Kim, Inho
    Park, Seonyang
    Park, Myoung Hee
    Kim, Byoung Kook
    Yoon, Sung-Soo
    Lee, Dong Soon
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1344 - 1350
  • [24] Stem cell transplantation for aplastic anemia and myelodysplastic syndrome
    Stary, J
    Locatelli, F
    Niemeyer, CM
    BONE MARROW TRANSPLANTATION, 2005, 35 (Suppl 1) : S13 - S16
  • [25] Myelodysplastic syndrome and aplastic anemia - diagnostic and conceptual uncertainties
    Barrett, J
    LEUKEMIA RESEARCH, 2000, 24 (07) : 595 - 596
  • [26] Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome
    Durrani, Jibran
    Maciejewski, Jaroslaw P.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 97 - 104
  • [27] Stem cell transplantation for aplastic anemia and myelodysplastic syndrome
    J Starý
    F Locatelli
    C M Niemeyer
    Bone Marrow Transplantation, 2005, 35 : S13 - S16
  • [28] A surveillance study to observe long-term safety of Exjade® in patients of myelodysplastic syndrome (MDS), aplastic anemia (AA) with transfusion-related iron overload
    Chang, M.
    Chiou, T.
    Chen, Y.
    Chang, T.
    Chang, C.
    Chen, Y. C.
    Hwang, W.
    Lin, S.
    Yeh, S.
    LEUKEMIA RESEARCH, 2013, 37 : S106 - S107
  • [29] Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS).
    Kordasti, Shahram Y.
    AlKhan, Sufyan M.
    Lim, Ziyi
    Abellan, Pilar Perez
    Marsh, Judith C. W.
    Mufti, Ghulam J.
    BLOOD, 2009, 114 (22) : 448 - 449
  • [30] Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome
    Wlodarski, Marcin W.
    Gondek, Lukasz P.
    Nearman, Zachary P.
    Plasilova, Magdalena
    Kalaycio, Matt
    Hsi, Eric D.
    Maciejewski, Jaroslaw P.
    BLOOD, 2006, 108 (08) : 2632 - 2641
12345